Find the latest pharmaceutical market place for formulations enquiry about Imipenem on PharmaCompass.com.

Various Finished Dosage Formulations needed in Vietnam [ENA12551]

A company that deals in the distribution of a wide range of products in allopathic formulations, herbal formulations, nutraceuticals, vaccines and orthopedic implants is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The required quantity is 500,000 units for each.
1. Imipenem (250 mg & 500 mg) + Cilastatin (250 mg & 500 mg) Injections or Infusions
2. Ketoconazole (200 mg) Suppositories
3. Letrozole (2.5 mg) Tablets
4. Levodopa (100 mg & 250 mg) + Carbidopa (10 mg & 25 mg) Tablets
5. Levofloxacin (500 mg/ 100 ml) Injections or Infusions
6. Levofloxacin (5%) Eye Drops

Reply

29 Jan 2022

SaudiArabia Flag

Imipenem+Cilastatin Injections (500mg; 500mg) needed in Saudi Arabia [ENA06213]

RMZ Pharma, one of the major national importers, exporters, distributors for pharmaceutical, herbal and cosmetic products is looking for suppliers of Imipenem+Cilastatin Injection (500mg; 500mg). The quantity required will be 14,700 vls and 7,300 vls for the above mentioned formulation. The suppliers must be FDA, MHRA or European approved. Interested suppliers can directly reach out to them via email: rmzpharma.sales@gmail.com.

Reply

06 Jan 2020

Meropenem & Imipenem Injections needed in Egypt [ENA05874]

A pharmaceutical company pursuing an ambitious strategy for driving business by providing a robust, futuristic platform in terms of technology and quality is looking for suppliers of Injections.
1. Meropenem (500 mg) IV vials: Qty: 250,000 units
2. Meropenem (1000 mg) IV vials: Qty: 250,000 units
3. Imipenem (500 mg) IV vials: Qty: 500,000 units

Reply

27 Nov 2019

Enquiry// Imipenem + Cilastatin, Rituximab, Sorafenib Tosylate and various other finished formulations needed in ...

Empower School of Health LLP, a consulting organization based in India is searching for following finished dosage formulations for one of their clients:
1. Imipenem + Cilastatin
2. Rituximab
3. Sorafenib Tosylate
4. Docetaxel
5. Oxaliplatin
6. Paclitaxel
7. Cerebrolysin
Interested suppliers should contact Ms. Divya Tiwar via Email: analyst5@empowerschoolofhealth.org or Tel: +91.73.79.35.13.12 (India).

Reply

14 Jul 2017

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.